Divya Soni is a neuropharmacologist specializing in neurodegenerative disorders, with a primary research focus on Parkinson’s disease. She utilizes rotenone and 6-OHDA-induced animal models to study disease mechanisms and evaluate therapeutic strategies. Her work emphasizes improving drug bioavailability and enhancing blood-brain barrier (BBB) penetration using nanotechnology-based delivery systems. She is also skilled in formulation development, animal handling, and molecular techniques such as western blotting. Her research aims to bridge experimental pharmacology with clinical relevance, contributing to the development of effective, targeted treatments for neurological conditions. She is committed to advancing therapeutic solutions for neurodegenerative diseases.